Preventing Damage Limitation: Targeting DNA-PKcs and DNA Double-Strand Break Repair Pathways for Ovarian Cancer Therapy
| Autor: | Euan A. Stronach, Daniela A. Dungl, Elaina N. Maginn |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Cancer Research
chemosensitisation DNA damage DNA repair Review Biology Bioinformatics lcsh:RC254-282 chemistry.chemical_compound medicine DNA-PKcs Cancer lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens medicine.disease platinum resistance chemosensitization Double Strand Break Repair ovarian cancer Oncology chemistry Cancer research Homologous recombination Ovarian cancer DNA |
| Zdroj: | Frontiers in Oncology Frontiers in Oncology, Vol 5 (2015) |
| ISSN: | 2234-943X |
| DOI: | 10.3389/fonc.2015.00240 |
| Popis: | Platinum-based chemotherapy is the cornerstone of ovarian cancer treatment, and its efficacy is dependent on the generation of DNA damage, with subsequent induction of apoptosis. Inappropriate or aberrant activation of the DNA damage response network is associated with resistance to platinum, and defects in DNA repair pathways play critical roles in determining patient response to chemotherapy. In ovarian cancer, tumor cell defects in homologous recombination – a repair pathway activated in response to double-strand DNA breaks (DSB) – are most commonly associated with platinum-sensitive disease. However, despite initial sensitivity, the emergence of resistance is frequent. Here, we review strategies for directly interfering with DNA repair pathways, with particular focus on direct inhibition of non-homologous end joining (NHEJ), another DSB repair pathway. DNA-dependent protein kinase catalytic subunit (DNA-PKcs) is a core component of NHEJ and it has shown considerable promise as a chemosensitization target in numerous cancer types, including ovarian cancer where it functions to promote platinum-induced survival signaling, via AKT activation. The development of pharmacological inhibitors of DNA-PKcs is on-going, and clinic-ready agents offer real hope to patients with chemoresistant disease. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|